These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35115506)

  • 1. Genetically stable CRISPR-based kill switches for engineered microbes.
    Rottinghaus AG; Ferreiro A; Fishbein SRS; Dantas G; Moon TS
    Nat Commun; 2022 Feb; 13(1):672. PubMed ID: 35115506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Deadman' and 'Passcode' microbial kill switches for bacterial containment.
    Chan CT; Lee JW; Cameron DE; Bashor CJ; Collins JJ
    Nat Chem Biol; 2016 Feb; 12(2):82-6. PubMed ID: 26641934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid Vectors for
    Kan A; Gelfat I; Emani S; Praveschotinunt P; Joshi NS
    ACS Synth Biol; 2021 Jan; 10(1):94-106. PubMed ID: 33301298
    [No Abstract]   [Full Text] [Related]  

  • 4. Recoded organisms engineered to depend on synthetic amino acids.
    Rovner AJ; Haimovich AD; Katz SR; Li Z; Grome MW; Gassaway BM; Amiram M; Patel JR; Gallagher RR; Rinehart J; Isaacs FJ
    Nature; 2015 Feb; 518(7537):89-93. PubMed ID: 25607356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Kill Switch Toxins in Plant-Beneficial
    Halvorsen TM; Ricci DP; Park DM; Jiao Y; Yung MC
    ACS Synth Biol; 2022 Nov; 11(11):3785-3796. PubMed ID: 36346907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing CRISPR-Cas systems for precision engineering of designer probiotic lactobacilli.
    Goh YJ; Barrangou R
    Curr Opin Biotechnol; 2019 Apr; 56():163-171. PubMed ID: 30530241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.
    Lu TK; Collins JJ
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4629-34. PubMed ID: 19255432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering a CRISPR Interference System To Repress a Class 1 Integron in Escherichia coli.
    Li Q; Zhao P; Li L; Zhao H; Shi L; Tian P
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models.
    Hwang IY; Koh E; Wong A; March JC; Bentley WE; Lee YS; Chang MW
    Nat Commun; 2017 Apr; 8():15028. PubMed ID: 28398304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering conjugative CRISPR-Cas9 systems for the targeted control of enteric pathogens and antibiotic resistance.
    Sheng H; Wu S; Xue Y; Zhao W; Caplan AB; Hovde CJ; Minnich SA
    PLoS One; 2023; 18(9):e0291520. PubMed ID: 37699034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications.
    Yu M; Hu S; Tang B; Yang H; Sun D
    Biotechnol Adv; 2023 Oct; 67():108202. PubMed ID: 37343690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midbiotics: conjugative plasmids for genetic engineering of natural gut flora.
    Ruotsalainen P; Penttinen R; Mattila S; Jalasvuori M
    Gut Microbes; 2019; 10(6):643-653. PubMed ID: 30951393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Design of Evolutionarily Stable Microbial Kill Switches.
    Stirling F; Bitzan L; O'Keefe S; Redfield E; Oliver JWK; Way J; Silver PA
    Mol Cell; 2017 Nov; 68(4):686-697.e3. PubMed ID: 29149596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox.
    Pedrolli DB; Ribeiro NV; Squizato PN; de Jesus VN; Cozetto DA;
    Trends Biotechnol; 2019 Jan; 37(1):100-115. PubMed ID: 30318171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins.
    Seo EJ; Weibel S; Wehkamp J; Oelschlaeger TA
    Int J Med Microbiol; 2012 Nov; 302(6):276-87. PubMed ID: 22748509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Cassettes for pH-Mediated Sensing, Counting, and Containment.
    Stirling F; Naydich A; Bramante J; Barocio R; Certo M; Wellington H; Redfield E; O'Keefe S; Gao S; Cusolito A; Way J; Silver P
    Cell Rep; 2020 Mar; 30(9):3139-3148.e4. PubMed ID: 32130913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically stable kill-switch using "demon and angel" expression construct of essential genes.
    Kato Y; Mori H
    Front Bioeng Biotechnol; 2024; 12():1365870. PubMed ID: 38481573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation.
    Riglar DT; Giessen TW; Baym M; Kerns SJ; Niederhuber MJ; Bronson RT; Kotula JW; Gerber GK; Way JC; Silver PA
    Nat Biotechnol; 2017 Jul; 35(7):653-658. PubMed ID: 28553941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthogonal Modular Gene Repression in Escherichia coli Using Engineered CRISPR/Cas9.
    Didovyk A; Borek B; Hasty J; Tsimring L
    ACS Synth Biol; 2016 Jan; 5(1):81-8. PubMed ID: 26390083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut.
    Praveschotinunt P; Duraj-Thatte AM; Gelfat I; Bahl F; Chou DB; Joshi NS
    Nat Commun; 2019 Dec; 10(1):5580. PubMed ID: 31811125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.